The aim of the study was to evaluate atherosclerosis in ankylosing spondylitis (AS) through the assessment of morphological and functional measures of subclinical atherosclerosis. Twenty patients [M/F=12/8, age (median/range) 43.5/28-69 years; disease duration (median/range) 9.7/1-36) years] with AS classified according to modified New York criteria and twenty age and sex related healthy controls with negative past medical history for cardiovascular events were enrolled in the study. In all patients and controls, the intima-media thickness (IMT) of common carotid artery, carotid bulb and internal carotid artery, and the flow-mediated dilatation (FMD) of non-dominant arm brachial artery were determined, using a sonographic probe Esaote GPX (Genoa, Italy). Furthermore, we assess the main disease activity and disability indices [bath ankylosing spondylitis disease activity index, ankylosing spondylitis disease activity score-eritrosedimentation rate (ASDAS-ESR), ASDAS-C-reactive protein (CRP), bath ankylosing spondylitis metrology index, bath ankylosing spondylitis functional index) and acute phase reactants. Plasmatic values of total cholesterol, low-density lipoprotein, high-density lipoprotein, triglyceride and homocysteine were carried out in all twenty patients. IMT at carotid bulb was significant higher in patients than in controls (0.67 mm vs 0.54 mm; P=0.03). FMD did not statistically differ between patients and controls (12.5% vs 15%; P>0.05). We found a correlation between IMT at carotid bulb and ESR (rho 0.43; P=0.04). No correlation was found between FMD and disease activity and disability indices. This study showed that in AS patients, without risk factors for cardiovascular disease, carotid bulb IMT, morphological index of subclinical atherosclerosis, is higher than in controls.
n INTRODUCTION A nkylosing spondylitis (AS) is a chronic systemic inflammatory disease that predominantly affects axial skeleton, with a possible peripheral and extra-articular involvement. AS patients have an increased mortality in respect to the general population (1), due to approximately 40% of cardiovascular disease cases, representing the leading cause of death (2) . Several studies demonstrated the presence of an accelerated atherosclerotic process and increased cardiovascular morbidity and mortality in patients with chronic rheumatic diseases (3) (4) (5) . In fact, it has been estimated that the relative risk of developing atherosclerotic disease is 3 in rheumatoid arthritis (3), 4-8 in systemic lupus erythematosus (6) and 1.2-1.8 in AS (7) compared to the general population. The link between inflammation and atherosclerosis is supported by observational studies performed on a large series of patients. These studies showed a close correlation between serum levels of acute phase reactants, in particular Creactive protein (CRP), and an increased risk of acute myocardial infarction, stroke and peripheral vascular disease. Also, CRP in long-standing rheumatoid arthritis patients correlated with the presence of subclinical atherosclerosis. Likewise, chronic inflammation determined by CRP levels over an extended follow-up was also found to be associated with the development of cardiovascular events and cardiovascular mortality in rheumatoid arthritis (3, 6, (8) (9) (10) (11) . The expression of cytokines and pro-inflammatory mediators plays a crucial role in all phases of atherosclerotic process in patients with rheumatic diseases (12) . The presence of subclinical atherosclerosis could be detected by non-invasive ultrasonographic tools, through the assessment of carotid intima-media thickness (IMT) (13) (14) (15) and flow-mediated dilatation (FMD) (16, 17) . Both methods are closely related to endothelial damage and dysfunction, early markers of atherosclerosis (18, 19). Prospective and retrospective studies showed that the assessment of endothelial function and arterial wall morphology could be useful in identifying patients at high risk of atherosclerosis and to predict the risk of developing cardiovascular events (19) (20) (21) . Recently, it has been demonstrated that patients with rheumatoid arthritis and psoriatic arthritis have an increased IMT of carotid wall and abnormalities of FMD (22) (23) (24) (25) (26) . The prevalence of increased subclinical atherosclerosis has been studied in AS through the assessment of IMT and FMD, but the presence of positive or negative history for cardiovascular risk factors, cardiovascular events or concomitant medications, have led to ambiguous results (27) (28) (29) (30) (31) (32) . Furthermore, in the assessment of carotid IMT, it was not considered the evaluation of different arterial segments (common carotid artery, internal carotid artery and bulb), characterized by a different progression of atherosclerotic process (33, 34) . Finally IMT and FMD were analyzed in the same patients only in few studies (27, 31) and the correlations of these indices of subclinical atherosclerosis with the disease activity or disability indices must be better defined. 
Carotid intima-media thickness
Scanning was performed on the patient's carotid arteries in the supine position with the neck extended. The probe was placed in the longitudinal plane at the anterolateral position of the right side of the neck then followed by the left side of the neck. The measurement of carotid artery IMT was obtained at three sites: 1 cm distally to carotid bulb in common carotid artery (CCA), at carotid bulb (BULB), and 1 cm proximally to carotid bulb in the internal carotid artery (ICA) ( bilaterally, after freezing the image on each occasion. IMT was defined as the distance between the inner echogenic line representing the intima-blood interface and the outer echogenic line representing the adventitia media junction. It was measured along the near and far wall of carotid artery. Furthermore, carotid bulb was defined as the point where the far wall deviated away from the parallel plane of the distal common carotid artery. Pathological IMT was defined as IMTm greater than 0.9 mm (40).
Flow-mediated dilatation of brachial artery
Evaluation of FMD was obtained by longitudinal B-mode US scan of the brachial artery, approximately 5 cm above the elbow of the non-dominant arm. The evaluation of the arteriolar diameter was performed at baseline and after hyperemia induced by applying sphygmomanometer inflated to a pressure of about 50 mmHg higher than the systolic blood pressure for 5 min. The arteriolar diameter after induced hyperemia was obtained at 30s, 60s, 90s and 120s, synchronizing the measurements with the R-wave electrocardiogram. We calculated FMD as the maximum percentage increase (FMD%) and as maximal difference (ΔFMD) of brachial artery diameter after induced hyperemia in comparison with baseline. All measurements were performed in a temperature controlled room, with the patient fasted for at least 12 h. All medications, caffeine intake or smoke were discontinued at least 24 hours prior to the exam. and FMD values (median/25 th -75 th percentile) of AS patients and healthy controls are reported in Table II . IMT values at BULB were significantly higher in patients than in controls (P=0.03) (Fig. 2) th percentile/range) at carotid bulb in ankylosing spondylitis patients (n=20) and controls (n=20) (p=0.03). (29) . It should be noted that in relation to risk factors that could modify IMT (41) (42) (43) in this study there were higher levels of plasma cholesterol and glucose in controls than in patients (29) . Similar results have also been obtained in other studies (30, 31) , which have not considered the bias of the presence of certain cardiovascular risk factors. However, when the criteria of exclusion included the presence of cardiovascular risk factors or cardiovascular events, it has been demonstrated an increased prevalence of subclinical atherosclerosis in AS (27, 28) . In fact, Bodnar et al. demonstrated increase IMT values at CCA level and a reduction of FMD in 43 AS patients compared to controls (27) . Similar results were obtained by Hamdi et al. in a study on 60 AS patients and controls with no history of risk factors or cardiovascular events. In this study CCA IMT values were significantly higher in patients with AS than in controls (0.51 mm vs 0.39 mm, P=0.001) (28) . Gonzales Juanatey et al. also found increased IMT values and prevalence of atherosclerotic plaques in a cohort of 64 patients with AS with respect to controls. Moreover, the best predictor of carotid plaques in patients with AS was ESR at time of disease diagnosis (32) . It has to be highlighted that these studies did not consider the evaluation of single carotid segments. This aspect is particularly important in relation to the evidence that the classic risk factors for atherosclerosis may have a different impact on the intima-media thickness in relation to anatomical sites (33) . Moreover, the progression of IMT is not homogeneous in the different arterial segments, and could be greater at BULB and ICA level (34) . In our study, the evidence of IMT values significantly increased in patients with AS compared to controls only at carotid bulb segment confirms that the evaluation of this district is essential in the study of subclinical atherosclerosis. In fact, in this anatomical site, changes in endothelial structure and turbulence due to carotid bifurcation may predispose to endothelial damage. With regards to the assessment of endothelial dysfunction by FMD, we have not found significant differences between patients and controls in the endotheliummediated response or correlation with disease activity and disability indices, according to other authors (31) . However, Bodnar found a reduction of FMD in his cohort of AS patients (27) . Changes in FMD assessment methods (for example the different time of occlusion) could explain the differences among these studies (44) . The discrepancy in IMT and FMD findings among different studies could also be explained with the presence of concomitant medications such as non steroidal anti-inflammatory drugs (NSAIDs), selective inhibitors of cyclooxygenase type 2 (coxibs) and TNFα inhibitors commonly used in AS. In fact, NSAIDs and coxibs may be able to alter the vasodilator response endothelium mediated by production of vasoactive substances (45), while anti-TNFα drugs can induce significant changes in carotid atherosclerotic progression and improve endothelial function (46, 47). However, it should be noted that in our study AS patients were not treated with anti-TNFα drugs and discontinued NSAIDs or coxibs at least 24 h before the test. Moreover, inflammatory burden in AS patients is often less severe than in psoriatic arthritis or rheumatoid ar- 
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